Cargando…

Comparing the needs and preferences of patients with moderate and severe dry eye symptoms across four countries

BACKGROUND/AIMS: Understanding patients’ perspectives of their disease can inform drug development and treatment decisions. In this study, we compared the preferences and needs of patients with moderate and severe dry eye symptoms from four different countries. METHODS: A quantitative questionnaire...

Descripción completa

Detalles Bibliográficos
Autores principales:	Messmer, Elisabeth, Chan, Colin, Asbell, Penny, Johnson, Gary, Sloesen, Brigitte, Cook, Nigel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936582/ https://www.ncbi.nlm.nih.gov/pubmed/31909193 http://dx.doi.org/10.1136/bmjophth-2019-000360

Ejemplares similares

Defining the needs and preferences of patients with dry eye disease
por: Asbell, Penny, et al.
Publicado: (2019)

Patient-reported burden and overall impact of dry eye disease across eight European countries: a cross-sectional web-based survey
por: Boboridis, Kostas G, et al.
Publicado: (2023)

The Growing Need for Validated Biomarkers and Endpoints for Dry Eye Clinical Research
por: Roy, Neeta S., et al.
Publicado: (2017)

Dry Eye Subtypes in the Dry Eye Assessment and Management (DREAM) Study: A Latent Profile Analysis
por: Yu, Kimberley, et al.
Publicado: (2022)

Association of Ocular Surface Immune Cells With Dry Eye Signs and Symptoms in the Dry Eye Assessment and Management (DREAM) Study
por: Kuklinski, Eric J., et al.
Publicado: (2023)

Age Associations with Dry Eye Clinical Signs and Symptoms in the Dry Eye Assessment and Management (DREAM) Study
por: Zhao, Megan, et al.
Publicado: (2023)

Assessing the Quality, Reliability, and Readability of Online Information on Dry Eye Disease
por: Oydanich, Marko, et al.
Publicado: (2022)

Development and content validity assessment of the Dry Eye Disease Questionnaire in patients with dry eye disease, meibomian gland dysfunction, and Sjögren’s syndrome dry eye disease
por: Sloesen, Brigitte, et al.
Publicado: (2023)

Patient and physician perspectives on the use of cyclosporine ophthalmic emulsion 0.05% for the management of chronic dry eye
por: Deveney, Tatiana, et al.
Publicado: (2018)

Association of Tear Osmolarity With Signs and Symptoms of Dry Eye Disease in the Dry Eye Assessment and Management (DREAM) Study
por: Greiner, Jack V., et al.
Publicado: (2023)

Corneal permeability changes in dry eye disease: an observational study
por: Fujitani, Kenji, et al.
Publicado: (2016)

Fluorophotometry as a diagnostic tool for the evaluation of dry eye disease
por: Fahim, Magid M, et al.
Publicado: (2006)

Climatic and Environmental Correlates of Dry Eye Disease Severity: A Report From the Dry Eye Assessment and Management (DREAM) Study
por: Berg, Erich J., et al.
Publicado: (2020)

A Randomized Study of the Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in Treatment of Moderate to Severe Dry Eye
por: Baudouin, Christophe, et al.
Publicado: (2017)

Modulation of HLA-DR in dry eye patients following 30 days of treatment with a lubricant eyedrop solution
por: Fernandez, Karen B, et al.
Publicado: (2015)

Real-World Experience with Lifitegrast Ophthalmic Solution (Xiidra(®)) in the US and Canada: Retrospective Study of Patient Characteristics, Treatment Patterns, and Clinical Effectiveness in 600 Patients with Dry Eye Disease
por: Hovanesian, John A, et al.
Publicado: (2021)

Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease Due to Meibomian Gland Disease
por: Steven, Philipp, et al.
Publicado: (2017)

Defining Dry Eye from a Clinical Perspective
por: Tsubota, Kazuo, et al.
Publicado: (2020)

Management of inflammation in dry eye disease: Recommendations from a European panel of experts
por: Messmer, Elisabeth M, et al.
Publicado: (2022)

Autologous serum eye drops in dry eye disease: Preferred practice pattern guidelines
por: Vazirani, Jayesh, et al.
Publicado: (2023)

Management of cataract in dry eye disease: Preferred practice pattern guidelines
por: Donthineni, Pragnya R, et al.
Publicado: (2023)

Benefits and Safety of Astaxanthin in the Treatment of Mild-To-Moderate Dry Eye Disease
por: Tian, Lei, et al.
Publicado: (2022)

Clinical impact of inflammation in dry eye disease: proceedings of the ODISSEY group meeting
por: Baudouin, Christophe, et al.
Publicado: (2017)

Management of corneal perforations in dry eye disease: Preferred practice pattern guidelines
por: Kate, Anahita, et al.
Publicado: (2023)

Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction
por: Baudouin, Christophe, et al.
Publicado: (2016)

Comparing the efficacy of sodium hyaluronate eye drops and carboxymethylcellulose eye drops in treating mild to moderate dry eye disease
por: Salim, Sreelakshmi, et al.
Publicado: (2023)

Subconjunctival Sirolimus-Loaded Liposomes for the Treatment of Moderate-to-Severe Dry Eye Disease
por: Salcedo-Ledesma, Alfredo, et al.
Publicado: (2023)

The Enduring Experience in Dry Eye Diagnosis: A Non-Interventional Study Comparing the Experiences of Patients Living With and Without Sjögren’s Syndrome
por: Figueiredo, Francisco C., et al.
Publicado: (2021)

Patient Medication Preferences for Managing Dry Eye Disease: The Importance of Medication Side Effects
por: Ozdemir, Semra, et al.
Publicado: (2022)

Symptom Burden of Patients with Dry Eye Disease: A Four Domain Analysis
por: Hallak, Joelle A., et al.
Publicado: (2013)

Evaluating Patient Experiences in Dry Eye Disease Through Social Media Listening Research
por: Cook, Nigel, et al.
Publicado: (2019)

Neuroticism, rumination, depression and suicidal ideation: A moderated serial mediation model across four countries
por: Vidal-Arenas, Verónica, et al.
Publicado: (2022)

Establishment of the mild, moderate and severe dry eye models using three methods in rabbits
por: Li, Na, et al.
Publicado: (2013)

Topical Omega-3 Polyunsaturated Fatty Acids for the Treatment of Dry Eye – Results from a Pilot Randomized Controlled Masked-Observer Study
por: Kaercher, Thomas, et al.
Publicado: (2022)

Blood-Based Treatments for Severe Dry Eye Disease: The Need of a Consensus
por: Bernabei, Federico, et al.
Publicado: (2019)

Comparison of 0.2% and 0.18% hyaluronate eye drops in patients with moderate to severe dry eye with keratitis or keratoconjunctivitis
por: Groß, Dorothea, et al.
Publicado: (2017)

Patient Preference Studies During Early Drug Development: Aligning Stakeholders to Ensure Development Plans Meet Patient Needs
por: Cook, Nigel S., et al.
Publicado: (2019)

International patient preferences for physician attire: results from cross-sectional studies in four countries across three continents
por: Houchens, Nathan, et al.
Publicado: (2022)

Patient-Reported Ocular Disorders and Symptoms in Adults with Moderate-to-Severe Atopic Dermatitis: Screening and Baseline Survey Data from a Clinical Trial
por: Weyne, Jonathan, et al.
Publicado: (2020)

Efficacy and safety of using topical cyclosporine A for treatment of moderate to severe dry eye disease
por: Othman, Tageldin M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qrp03k5qjea9dbf9jv2rp0ej5f